In a first, FDA signs off on CellTrans' type 1 diabetes cell therapy days after industry's eyes fixated on Vertex data - Endpoints News
endpts.comSubmitted by endpointsnews6292 in business
Certain patients with type 1 diabetes now have an option to use cell therapy thanks to a new FDA approval. The agency greenlit on Wednesday CellTrans’ pancreatic islet cell therapy, which takes pancreatic cells from deceased donors. FDA OK’d the first-of-its-…